Senolytics, dasatanib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease. [PDF]
EBioMedicineBian X +11 more
europepmc +1 more source
Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review. [PDF]
Transl Breast Cancer ResStravodimou A, Voutsadakis IA.
europepmc +1 more source
Integrating Senescence and Oxidative Stress in Cardiac Disease. [PDF]
Int J Mol SciYun HR +6 more
europepmc +1 more source
SDC4 silencing promotes cell cycle arrest at the restriction point (R point) in anoikis-resistant endothelial cells. [PDF]
CytotechnologyFerreira BZF +6 more
europepmc +1 more source
p16-mediated G0/G1 cell cycle arrest leads to SASP and fibrosis in Fuchs endothelial corneal dystrophy. [PDF]
Cell Death DisParekh M +6 more
europepmc +1 more source
Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer. [PDF]
Genes (Basel)Zou E +9 more
europepmc +1 more source
Cyclin-Dependent Kinases 4 and 6 Inhibitors: An Emerging Therapeutic Framework from Growth Suppression to Tumor Clearance. [PDF]
ACS Pharmacol Transl SciMa C +7 more
europepmc +1 more source
Frontiers in Cell-Cycle-Targeting Therapies: Addressing the Heterogeneity of the Cancer Cell Cycle. [PDF]
Cancers (Basel)Ganesan IP, Kiyokawa H.
europepmc +1 more source
Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors. [PDF]
J Hematol OncolSafaroghli-Azar A +4 more
europepmc +1 more source